Clopidogrel in the treatment and prophylaxis of cerebrovascular diseases
We consider the possibility of modern antiplatelets use such as clopidogrel in the treatment and prevention of acute disorders of cerebral circulation. According to the multicenter clinical studies database, antiplatelet therapy effectively prevents stroke, myocardial infarction and mortality from cardiovascular causes in patients with symptomatic atherosclerosis. The complexity of clopidogrel action (antiplatelet, hemangiocorrective, lipid-lowering activity) along with its high clinical efficacy can recommend this drug to a wide range of patients with ischemic cerebrovascular diseases: in the secondary prevention of thrombotic events in patients with multiple lesions of the vascular system; in the secondary ischemic stroke prevention and after reparative surgeries on the carotid arteries.